ANTIMICROBIAL SUSCEPTIBILITY OF HAEMOPHILUS-INFLUENZAE, NEISSERIA-MENINGITIDIS AND STREPTOCOCCUS-PNEUMONIAE ISOLATES CAUSING MENINGITIS IN THE NETHERLANDS, 1993-1994
Rh. Enting et al., ANTIMICROBIAL SUSCEPTIBILITY OF HAEMOPHILUS-INFLUENZAE, NEISSERIA-MENINGITIDIS AND STREPTOCOCCUS-PNEUMONIAE ISOLATES CAUSING MENINGITIS IN THE NETHERLANDS, 1993-1994, Journal of antimicrobial chemotherapy, 38(5), 1996, pp. 777-786
The increasing antimicrobial resistance among pathogens frequently iso
lated from patients with bacterial meningitis formed the rationale to
perform a surveillance study to determine the prevalence of resistance
in The Netherlands. Haemophilus influenzae strains (n = 316) isolated
from cerebrospinal fluid (CSF), 1125 meningococcal strains isolated f
rom blood or CSF and 398 pneumococcal strains isolated from CSF in 199
3 and 1994 were tested by the Etest for susceptibility to commonly pre
scribed antibiotics for the treatment of community-acquired meningitis
. In H. influenzae strains ampicillin-resistance occurred in 7.0%, res
istance to chloramphenicol in 2.2%, and resistance to both antibiotics
in 0.9%. The prevalence of intermediate penicillin-resistance in meni
ngococci was 3.3%. Resistance to rifampicin was rarely found (0.1%). I
ntermediate penicillin-resistance in pneumococci was found in only 0.5
% of isolates. All 1839 isolates were susceptible to ceftriaxone. Base
d on these results, we conclude that empirical therapy of childhood co
mmunity-acquired bacterial meningitis with amoxycillin and chloramphen
icol is no longer justified in children who have not been vaccinated a
gainst H. influenzae type b. In vaccinated or older children and adult
s, amoxycillin is a rational choice for empirical treatment of meningi
tis. The prophylactic use of rifampicin in contacts of patients with m
eningococcal disease is still applicable.